Researcher admits faking data

'Egregiousness' of conduct over almost 15 years leads to first-ever lifetime ban on US grants

Written byDoug Payne
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

A well known obesity researcher with more than 200 articles to his name will plead guilty to making material false statements in a 1999 grant application worth $542,000 from the US National Institutes of Health, according to a plea bargain announced Thursday (March 17) in Vermont. Eric Poehlman said he fabricated data in 17 applications for US federal grants and agreed to be barred for life "from seeking or receiving funding from any federal agency in the future, including all components of the Public Health Service."

Poehlman is expected to be arraigned either this week or next. The criminal charge—an unusual step for investigations of scientists—of fraud to which he agreed to plead guilty could see the researcher go to jail for up to 5 years.

However, it is possible he will serve little or no jail time. Stephen Kelly, a prosecutor in the US Attorney's office in Vermont, told ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform